Okay. Thanks for that.
Well, we have a nosocomial surveillance infection program here in Canada, 58 teaching hospitals. They've been monitoring this for more than a decade, but apparently they were not collecting data on the meds that people were on at admission, when they developed antibiotic-associated diarrhea or CDAD. Would you consider that a missed opportunity?